Cargando…

Impact of Sepsis on the Oncologic Outcomes of Advanced Epithelial Ovarian Cancer Patients: A Multicenter Observational Study

SIMPLE SUMMARY: There has been a growing interest in the interplay between the immune system and the prognosis of epithelial ovarian cancer (EOC). It has become clear that EOC has the ability to escape destruction by the immune system by creating a highly immunosuppressive microenvironment in the ab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Said, Sherin A., de Hullu, Joanne A., van der Aa, Maaike A., Walraven, Janneke E. W., Bekkers, Ruud L. M., Slangen, Brigitte F. M., Pickkers, Peter, van Altena, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526225/ https://www.ncbi.nlm.nih.gov/pubmed/37760610 http://dx.doi.org/10.3390/cancers15184642

Ejemplares similares

Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population‐based cohort study
por: Said, Sherin A., et al.
Publicado: (2021)

Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women
por: Hermens, Marjolein, et al.
Publicado: (2021)

Adequacy of family history taking in ovarian cancer patients: a population-based study
por: van Altena, Anne M., et al.
Publicado: (2012)

First step in implementation of opportunistic salpingectomy for prevention of ovarian cancer: Current care and its determinants
por: Gelderblom, Malou E., et al.
Publicado: (2023)

The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease
por: van der Linden, Michelle, et al.
Publicado: (2017)

Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking
por: Olthof, Ester Paulien, et al.
Publicado: (2022)

Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
por: den Ouden, Judith E., et al.
Publicado: (2020)

Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma
por: van Lieshout, Laura, et al.
Publicado: (2021)

Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers
por: Zaaijer, Leendert H, et al.
Publicado: (2016)

Intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in recurrent ovarian carcinoma patients (a phase I study)
por: Hoogstad-van Evert, Janneke, et al.
Publicado: (2019)

Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome
por: Reijnen, Casper, et al.
Publicado: (2020)

Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis
por: van Bommel, Majke H D, et al.
Publicado: (2022)

Endometrial Cancer Incidence in Endometriosis and Adenomyosis
por: Hermens, Marjolein, et al.
Publicado: (2021)

Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review
por: Walraven, Janneke E. W., et al.
Publicado: (2022)

Facilitators and barriers to conducting an efficient, competent and high-quality oncological multidisciplinary team meeting
por: Walraven, Janneke E W, et al.
Publicado: (2023)

Precision Immunotherapy for Sepsis
por: Peters van Ton, Annemieke M., et al.
Publicado: (2018)

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients
por: Hoogstad-van Evert, Janneke S., et al.
Publicado: (2018)

Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?
por: Laven, Pim, et al.
Publicado: (2021)

Preparing tomorrow’s medical specialists for participating in oncological multidisciplinary team meetings: perceived barriers, facilitators and training needs
por: Walraven, Janneke E. W., et al.
Publicado: (2022)

Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate
por: van Kol, Kim, et al.
Publicado: (2021)

Pros and cons of streamlining and use of computerised clinical decision support systems to future-proof oncological multidisciplinary team meetings
por: Walraven, Janneke E. W., et al.
Publicado: (2023)

Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3
por: van Lier, D., et al.
Publicado: (2020)

Umbilical cord blood CD34(+) progenitor-derived NK cells efficiently kill ovarian cancer spheroids and intraperitoneal tumors in NOD/SCID/IL2Rg(null) mice
por: Hoogstad-van Evert, Janneke S., et al.
Publicado: (2017)

Does the New FIGO 2018 Staging System Allow Better Prognostic Differentiation in Early Stage Cervical Cancer? A Dutch Nationwide Cohort Study
por: Ten Eikelder, Mieke L. G., et al.
Publicado: (2022)

Sentinel node in ovarian cancer: study protocol for a phase 1 study
por: Kleppe, Marjolein, et al.
Publicado: (2013)

Investigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the Netherlands
por: Meys, Evelyne MJ, et al.
Publicado: (2015)

Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands
por: Burg, Lara, et al.
Publicado: (2020)

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition
por: Vos, Janet R, et al.
Publicado: (2019)

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer: course over time and associated factors
por: van Bommel, Majke H. D., et al.
Publicado: (2022)

Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry
por: van der Ploeg, Phyllis, et al.
Publicado: (2021)

Sentinel lymph node procedure in patients with recurrent vulvar squamous cell carcinoma: a proposed protocol for a multicentre observational study
por: van Doorn, Helena C., et al.
Publicado: (2022)

Sufficient sleep quality easily measured: a multicenter centre study in dutch ICUS
por: Rood, P, et al.
Publicado: (2015)

Towards precision medicine for sepsis patients
por: Pickkers, Peter, et al.
Publicado: (2017)

What’s new in the extracorporeal treatment of sepsis?
por: Pickkers, Peter, et al.
Publicado: (2017)

Significant decrease of adenocarcinoma in situ not reflected in cervical adenocarcinoma incidence in the Netherlands 1989–2003
por: van de Nieuwenhof, H P, et al.
Publicado: (2008)

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome
por: Gerritzen, Lotte H. M., et al.
Publicado: (2009)

Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-κB Pathway Activity: A Novel Approach to a Long-Standing Enigma
por: van Lieshout, Laura, et al.
Publicado: (2020)

The progression-free survival ratio as outcome measure in recurrent ovarian carcinoma patients: Current and future perspectives
por: van de Kruis, Nienke, et al.
Publicado: (2022)

Surveillance of women at high risk for hereditary ovarian cancer is inefficient
por: Oei, A L, et al.
Publicado: (2006)

Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer
por: van Bommel, Majke H.D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_320tjhd72mih6v9cg974vcvi61